Elegen
San Carlos, US · Founded 2017 · Delaware corporation · 60 employees on LinkedIn · 8 known investors
Find your way into Elegen
Sign up to see every warm intro you have to Elegen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Elegen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Elegant Bio develops DNA synthesis technology and services, offering ENFINIA™ DNA synthesis at scale for biotech and research applications.
Founders & leadership
Elegen was founded in 2017 by Matthew Hill.

Board


Investors · 8
How we know: ACVC Partners's portfolio page · funding news · Not right? Tell us
How we know: a16z's portfolio · a partner's Signal profile · Not right? Tell us
How we know: In-Q-Tel's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · funding news · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$33M disclosed across 1 round · 2024
▶$33MraisedMay 2024 · 28 investors · OtherRule 506(b)
- Matthew HillExecutive Officer, Director
- Peter ZhouDirector
- Jonathan SheenaDirector
- Cain McClaryDirector
- Offering amount
- $36M
- Amount sold
- $33M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Elegen went on to found or lead other companies.
Related companies · 1
Companies working in the same space as Elegen.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $2M |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Elegen do?
- Elegant Bio develops DNA synthesis technology and services, offering ENFINIA™ DNA synthesis at scale for biotech and research applications.
- Who founded Elegen?
- Elegen was founded by Matthew Hill in 2017.
- Who are Elegen's investors?
- Elegen's investors include ACVC Partners, Andreessen Horowitz, In-Q-Tel, Raptor Group, Triatomic Capital, AME Cloud Ventures, Digitalis Ventures, KdT Ventures.
- How much funding has Elegen raised?
- Elegen has disclosed $33M raised across 1 round.
- Where is Elegen headquartered?
- Elegen is headquartered in San Carlos, US.








